The KU Cancer Center is working with Faith Works, a consortium of researchers and church leaders, to spread the word about the importance of cancer prevention and screenings among the African American community.
African Americans have the highest death rate and shortest survival rate for most cancers of any racial or ethnic group in the U.S. That’s why scientists at The University of Kansas Cancer Center are working hard to overcome these hurdles, and they’re doing it in a unique way.
Joaquina Baranda, M.D., leads the KU Cancer Center’s early-phase clinical trial program, which is the first step in taking new therapies from the research lab to the patient
Decades of basic (or bench) science has built the foundational knowledge needed to make advancements in the diagnosis, treatment and prevention of diseases, including cancer. That preclinical research has led to early-phase clinical trials and today’s leading-edge cancer treatments at The University of Kansas Cancer Center.